The vascular bed of spleen in health and disease

Endothelial Biomedicine

Volumn , Issue , 2007, Pages 1255-1264

  Balogh, Péter ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79959540763     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511546198.137     Document Type: Chapter

References (76)

1. Krumbhaar EB. Functions of the spleen: (Mysterii Plenum Organon) Galen. Physiol Rev. 1926;6:160-200.
2. Lewis SM. The spleen: mysteries solved and unresolved. Clin Haematol. 1983;12:363-373.
3. Brodsky I, Dennis LH, Kahn SB, Brody LW. Normal mouse ery-thropoiesis I. The role of the spleen in mouse erythropoiesis. CancerR.es. 1966;26:198-201.
4. Robertson S, Kennedy M, Keller G. Hematopoietic commitment during embryogenesis. Ann NY Acad Sci. 1999;872:9-15.
5. Barker JE, Keenan MA, Raphals L. Development of the mouse hematopoietic system. II. Estimation of spleen and liver “stem” cell number. J Cell Physiol. 1969;74:51-56.
6. Medvinsky AL, Dzierzak EA. Development of the definitive hematopoietic hierarchy in the mouse. Dev Comp Immunol. 1998;22:289-301.
7. Ganong WF. Review of Medical Physiology, 21st ed. New York: Appleton and Lange, Lange Medical Publications; 2003:627-628.
8. Steiniger B, Barth P. Microanatomy and function of the spleen. Adv Anat Embryol Cell Biol. 2000;151:1-101.
9. Fujita T, Kashimura M, Adachi K. Scanning electron microscopy and terminal circulation. Experientia. 1985;41:167-179.
10. Mitchell J. Lymphocyte circulation in the spleen. Marginal zone bridging channels and their possible role in cell traffic. Immunology. 1973;24:93-107.
11. Grayson MH, Hotchkiss RS, Karl IE, et al. Intravital microscopy comparing T lymphocyte trafficking to the spleen and the mesenteric lymph node. Am J Physiol Heart Circ Physiol. 2003;284: H2213-H2226.
12. Steiniger B, Barth P, Hellinger A. The perifollicular and marginal zones ofthe human splenic white pulp: do fibroblasts guide lymphocyte immigration? Am J Pathol. 2001;159:501-512.
13. Kraal G, Schornagel K, Streeter PR, et al. Expression of the mucosal vascular addressin, MAdCAM-1, on sinus-lining cells in the spleen. Am J Pathol. 1995;147:763-771.
14. Weiss L. The spleen in malaria: the role of barrier cells. Immunol Lett. 1990;25:165-172.
15. Steiniger B, Barth P, Herbst B, et al. The species-specific structure of microanatomical compartments in the human spleen: strongly sialoadhesin-positive macrophages occur in the perifollicular zone, but not in the marginal zone. Immunology. 1997;92:307-316.
16. Nolte MA, Belien JA, Schadee-Eestermans I, et al. A conduit system distributes chemokines and small blood-borne molecules through the splenic white pulp. J Exp Med. 2003;198:505-512.
17. Saitoh K, Kamiyama R, Hatakeyama S. A scanning electron microscopic study of the boundary zone of the human spleen. Cell Tissue Res. 1982;222:655-665.
18. Sasou S, Sugai T. Periarterial lymphoid sheath in the rat spleen: a light, transmission, and scanning electron microscopic study. AnatRec. 1992;232:15-24.
19. Papayannopoulou T, Craddock C, Nakamoto B, et al. The VLA4/VCAM-1 adhesion pathway defines contrasting mechanisms of lodgement of transplanted murine hemopoietic progenitors between bone marrow and spleen. Proc Natl Acad Sci USA. 1995;92:9647-9651.
20. Nitschke L, Floyd H, Ferguson DJ, Crocker PR. Identification of CD22 ligands on bone marrow sinusoidal endothelium implicated in CD22-dependent homing of recirculating B cells. J Exp Med. 1999;189:1513-1518.
21. Ueda H, Fujimori O, Abe M. Histochemical analysis of acidic gly-coconjugates in the endothelium lining the splenic blood vessels in the rat. Arch Histol Cytol. 1996;59:389-397.
22. Uehara K, Miyoshi M. Tight junction of sinus endothelial cells of the rat spleen. Tissue Cell. 1999;31:555-560.
23. Uehara K, Miyoshi M. Stress fiber networks in sinus endothelial cells in the rat spleen. Anat Rec. 1999;254:22-27.
24. Uehara K, Miyoshi M. Junctions between the sinus endothelial cells ofrat spleen. Cell Tissue Res. 1997;287:187-192.
25. Uehara K, Miyoshi M. The surface-connected canalicular system in the sinus endothelial cells of rat spleen. Cell Tissue Res. 1999;296:439-442.
26. Uehara K, Miyoshi M. Tubular invaginations with caveolae and coated pits in the sinus endothelial cells of the rat spleen. His-tochem Cell Biol. 1999;112:351-358.
27. Uehara K, Miyoshi M. Localization of caveolin-3 in the sinus endothelial cells ofthe rat spleen. Cell Tissue Res. 2002;307:329-336.
28. Aird WC. Endothelium as an organ system. Crit Care Med. 2004; 32:S271-S279.
29. Apelqvist A, Ahlgren U, Edlund H. Sonic hedgehog directs specialised mesoderm differentiation in the intestine and pancreas. CurrBiol. 1997;7:801-804.
30. Kawahira H, Ma NH, Tzanakakis ES, et al. Combined activities of hedgehog signaling inhibitors regulate pancreas development. Development. 2003;130:4871-4879.
31. Green MC. A defect of the splanchnic mesoderm caused by the mutant gene dominant hemimelia in the mouse. Dev Biol. 1967; 15:62-89.
32. Hecksher-Sorensen J, Watson RP, Lettice LA, et al. The splanchnic mesodermal plate directs spleen and pancreatic laterality, and is regulated by Bapx1/Nkx3.2. Development. 2004;131:4665-4675.
33. Searle AG. Hereditary absence of spleen in the mouse. Nature. 1959;184:1419-1420.
34. Roberts CW, Shutter JR, Korsmeyer SJ. Hox11 controls the genesis ofthe spleen. Nature. 1994;368:747-749.
35. Dear TN, Colledge WH, Carlton MB, et al. The Hox11 gene is essential for cell survival during spleen development. Development. 1995;121:2909-2915.
36. Kanzler B, Dear TN. Hox11 acts cell autonomously in spleen development and its absence results in altered cell fate of mesenchymal spleen precursors. Dev Biol. 2001;234:231-243.
37. Koehler K, Franz T, Dear TN. Hox11 is required to maintain normal Wt1 mRNA levels in the developing spleen. Dev Dyn. 2000;218:201-206.
38. Herzer U, Crocoll A, Barton D, etal. The Wilms tumor suppressor gene wt1 is required for development of the spleen. Curr Biol. 1999;9:837-840.
39. Tribioli C, Lufkin T. The murine Bapx1 homeobox gene plays a critical role in embryonic development ofthe axial skeleton and spleen. Development. 1999;126:5699-5711.
40. Lu J, Chang P, Richardson JA, et al. The basic helix-loop-helix transcription factor capsulin controls spleen organogenesis. Proc Natl Acad Sci USA. 2000;97:9525-9530.
41. Mok H, Mendoza M, Prchal JT, et al. Dysregulation of ferroportin 1 interferes with spleen organogenesis in polycythaemia mice. Development. 2004;131:4871-4881.
42. Pabst O, Forster R, Lipp M, et al. NKX2.3 is required for MAdCAM-1 expression and homing of lymphocytes in spleen and mucosa-associated lymphoid tissue. EMBOJ. 2000;19:2015-2023.
43. Wang CC, Biben C, Robb L, et al. Homeodomain factor Nkx2-controls regional expression of leukocyte homing coreceptor MAdCAM-1 in specialized endothelial cells of the viscera. Dev Biol. 2000;224:152-167.
44. Kallianpur AR, Jordan JE, Brandt SJ. The SCL/TAL-1 gene is expressed in progenitors of both the hematopoietic and vascular systems during embryogenesis. Blood. 1994;83:1200-1208.
45. Hwang LY, Siegelman M, Davis L, et al. Expression of the TAL1 proto-oncogene in cultured endothelial cells and blood vessels ofthe spleen. Oncogene. 1993;8:3043-3046.
46. Robb L, Elwood NJ, Elefanty AG, et al. The scl gene product is required for the generation of all hematopoietic lineages in the adult mouse. EMBO J. 1996;15:4123-4129.
47. Park C, Afrikanova I, Chung YS, et al. A hierarchical order of factors in the generation of FLK1-and SCL-expressing hematopoietic and endothelial progenitors from embryonic stem cells. Development. 2004;131:2749-2762.
48. Pajusola K, Aprelikova O, Korhonen J, et al. FLT4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines. Cancer Res. 1992;52:5738-5743.
49. Ward NL, Dumont DJ. The angiopoietins and Tie2/Tek: adding to the complexity of cardiovascular development. Semin Cell Dev Biol. 2002;13:19-27.
50. Arai F, Hirao A, Ohmura M, et al. Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell. 2004;118:149-161.
51. Koop EA, Lopes SM, Feiken E, et al. Receptor protein tyrosine phosphatase mu expression as a marker for endothelial cell heterogeneity; analysis of RPTPmu gene expression using LacZ knock-in mice. Int J Dev Biol. 2003;47:345-354.
52. Guillot PV, Guan J, Liu L, et al. A vascular bed-specific pathway. J Clin Invest. 1999;103:799-805.
53. Aird WC, Jahroudi N, Weiler-Guettler H, et al. Human von Wille-brand factor gene sequences target expression to a subpopulation of endothelial cells in transgenic mice. Proc Natl Acad Sci USA. 1995;92:4567-4571.
54. Fu YX, Chaplin DD. Development and maturation ofsecondary lymphoid tissues. Annu Rev Immunol. 1999;17:399-433.
55. Mackay F, Majeau GR, Lawton P, et al. Lymphotoxin but not tumor necrosis factor functions to maintain splenic architecture and humoral responsiveness in adult mice. Eur J Immunol. 1997;27:2033-2042.
56. Wang J, Foster A, Chin R, et al. The complementation of lymphotoxin deficiency with LIGHT, a newly discovered TNF family member, for the restoration of secondary lymphoid structure and function. Eur J Immunol. 2002;32:1969-1979.
57. Tumanov AV, Grivennikov SI, Shakhov AN, et al. Dissecting the role of lymphotoxin in lymphoid organs by conditional targeting. Immunol Rev. 2003;195:106-116.
58. Girkontaite I, Sakk V, Wagner M, et al. The sphingosine-1-phosphate (S1P) lysophospholipid receptor S1P3 regulates MAdCAM-1+ endothelial cells in splenic marginal sinus organization. J Exp Med. 2004;200:1491-1501.
59. Stuart AE, Warford A. Staining of human splenic sinusoids and demonstration of unusual banded structures by monoclonal antisera. J Clin Pathol. 1983;36:1176-1180.
60. Buckley PJ, Dickson SA, Walker WS. Human splenic sinusoidal lining cells express antigens associated with monocytes, macrophages, endothelial cells, and T lymphocytes. J Immunol. 1985;134:2310-2315.
61. Balazs M, Grama L, Balogh P. Detection of phenotypic heterogeneity within the murine splenic vasculature using rat monoclonal antibodies IBL-7/1 and IBL-7/22. Hybridoma. 1999; 18:177-182.
62. BaMzs M, Horvath G, Grama L, Balogh P. Phenotypic identification and development of distinct microvascular compartments in the postnatal mouse spleen. Cell Immunol. 2001;212:126-137.
63. Falkowski M, Schledzewski K, Hansen B, Goerdt S. Expression of stabilin-2, a novel fasciclin-like hyaluronan receptor protein, in murine sinusoidal endothelia, avascular tissues, and at solid/liquid interfaces. Histochem Cell Biol. 2003;120:361-369.
64. Matloubian M, David A, Engel S, et al. A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo. Nat Immunol. 2000;1:298-304.
65. Kennel SJ, Godfrey V, Ch’ang LY, et al. The beta 4 subunit of the integrin family is displayed on a restricted subset of endothelium in mice. J Cell Sci. 1992;101:145-150.
66. Hoek RM, Ruuls SR, Murphy CA, et al. Down-regulation of the macrophage lineage through interaction with OX2 (CD200). Science. 2000;290:1768-1771.
67. Duijvestijn AM, van Goor H, Klatter F, et al. Antibodies defining rat endothelial cells: RECA-1, a pan-endothelial cell-specific monoclonal antibody. Lab Invest. 1992;66:459-466.
68. Abbott RM, Levy AD, Aguilera NS, et al. From the archives of the AFIP: primary vascular neoplasms ofthe spleen: radiologic-pathologic correlation. Radiographics. 2004;24:1137-1163.
69. Kutok JL, Fletcher CD. Splenic vascular tumors. Semin Diagn Pathol. 2003;20:128-139.
70. Arber DA, Strickler JG, Chen YY, Weiss LM. Splenic vascular tumors: a histologic, immunophenotypic, and virologic study. Am J Surg Pathol. 1997;21:827-835.
71. Bautch VL, Toda S, Hassell JA, Hanahan D. Endothelial cell tumors develop in transgenic mice carrying polyoma virus middle T oncogene. Cell. 1987;51:529-537.
72. Williams RL, Risau W, Zerwes HG, et al. Endothelioma cells expressingthepolyoma middle T oncogene induce hemangiomas by host cell recruitment. Cell. 1989;57:1053-1063.
73. Yuen PH, Matherne CM, Molinari-Storey LM. SV7, a molecular clone of Moloney murine sarcoma virus 349, transforms vascular endothelial cells. Am J Pathol. 1991;139:1449-1461.
74. Fukasawa K, Vande Woude GF. Synergy between the Mos/mitogen-activated protein kinase pathway and loss of p53 function in transformation and chromosome instability. Mol Cell Biol. 1997;17:506-518.
75. Kleymenova E, Everitt JI, Pluta L, et al. Susceptibility to vascular neoplasms but no increased susceptibility to renal carcinogenesis in Vhl knockout mice. Carcinogenesis. 2004;25:309-315.
76. Barosi G, Rosti V, Massa M, et al. Spleen neoangiogenesis in patients with myelofibrosis with myeloid metaplasia. BrJHaematol. 2004;124:618-625.